5.3
CVE-2021-20832
- EPSS 0.24%
- Veröffentlicht 13.10.2021 09:15:08
- Zuletzt bearbeitet 21.11.2024 05:47:14
- Quelle vultures@jpcert.or.jp
- CVE-Watchlists
- Unerledigt
InBody App for iOS versions prior to 2.3.30 and InBody App for Android versions prior to 2.2.90(510) contain a vulnerability which may lead to information disclosure only when it works with the body composition analyzer InBody Dial. This may allow an attacker who can connect to the InBody Dial with InBody App may obtain a victim's measurement result measured by InBody Dial.
Daten sind bereitgestellt durch National Vulnerability Database (NVD)
| Typ | Quelle | Score | Percentile |
|---|---|---|---|
| EPSS | FIRST.org | 0.24% | 0.439 |
| Quelle | Base Score | Exploit Score | Impact Score | Vector String |
|---|---|---|---|---|
| nvd@nist.gov | 5.3 | 3.9 | 1.4 |
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
|
| nvd@nist.gov | 4.3 | 8.6 | 2.9 |
AV:N/AC:M/Au:N/C:P/I:N/A:N
|
CWE-200 Exposure of Sensitive Information to an Unauthorized Actor
The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information.